What’s New in Diabetic Kidney Disease

CME/CE Activity

The National Kidney Foundation (NKF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), an accredited provider by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation*, an accredited provider by the Commission on Dietetic Registration (CDR) and an accredited provider by the Association for Social Work Boards (ASWB) to provide continuing education to physicians, nurses/dialysis technicians, dietitians and social workers respectively. In addition, individual activities are approved on an activity specific basis for family physicians, advanced practitioners (nurse practitioners and physician assistants), pharmacists, certified case managers, certified rehabilitation counselors, and other specialties.

*Activity approvals: Prior to January 2012 through the New York State Nurses Association (NYSNA); January 2012-December 2012 through the Ohio Nurses Association (ONA).

Available through
Sep 21, 2019
The purpose of this activity is to discuss the pathophysiology and natural history of diabetic kidney disease, the novel drugs used to treat hyperkalemia and evaluate their appropriate use, and the mechanism of action of novel drugs under study for treating diabetic kidney disease.
Approved for: 1.5 **
Faculty: Vivek Bhalla, MD; Jamie Dwyer, MD; Katherine Tuttle, MD
Cost: Free for NKF Members / $25 for non-members